Free Daily Podcast Summary
The Readout Loud: Daily Summaries Delivered
by STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 4 days ago29 min
420: Democrats’ midterm victory, and a questionable fertility procedure
How will the midterm results affect drug pricing policy? What is the fate of the Food and Drug Administration? And why are women traveling to fertility clinics abroad? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on our Washington correspondent Daniel Payne to chat about the massive midterm victory for Democrats and what it means for health and medicine. We also bring on our colleague Megan Molteni to discuss her investigation into a network of clinics that have advertised fertility success with a questionable and expensive genetic procedure.
- 1 weeks ago20 min
419: Assessing Merck and Moderna's mRNA cancer vaccine
What is Adam doing in Spain? How did doctors react to detailed data on Merck and Moderna's mRNA cancer vaccine? And what are the next big advances in oncology? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on our colleague Andrew Joseph to discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology. We also make an announcement about the podcast.
- 2 weeks ago35 min
418: Remembering STAT’s Helen Branswell
Helen Branswell was a renowned infectious disease reporter who earned the respect and admiration of experts and public health officials with her authoritative, prescient reporting on the flu, polio, Ebola and the Covid-19 pandemic. This week’s episode of “The Readout LOUD” is dedicated to Helen, who died last week due to complications of cancer. We speak with her colleagues at STAT, family and public health leaders about her work and her legacy.
- 3 weeks ago20 min
417: Hospitals' next lucrative bet — longevity clinics
Longevity medicine is now estimated to be a multitrillion dollar industry. But what are people paying for, and does it work? On this week's episode of “The Readout LOUD,” STAT's biotech podcast, we bring on STAT reporter Sarah Todd to discuss the booming industry of longevity health and her visit to one of the many longevity clinics popping up in major hospitals across the country.
- Oct 8, 202633 min
416: NIH funding uncertainty thwarts U.S. researchers
How has the National Institutes of Health been spending its budget? Why are biotech investors feeling gloomy? And what is the most quintessential Boston movie? We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. We bring on STAT reporter Anil Oza and Heather Pierce, senior director of science policy at the Association of American Medical Colleges, to discuss the how the NIH distributed its money in the latest funding cycle and the effects on U.S. biomedical research. We also chat about the shuttering of a CRISPR CAR-T biotech, the Nobel Prize in medicine, and biotech investors’ current mood.
- Oct 1, 202631 min
415: Mistrust in science and a juicy gene-editing lawsuit
On this week’s episode of "The Readout LOUD": Why have so many Americans lost trust in science? And how have our policy leaders fueled that mistrust? We speak to STAT’s new trust-in-science reporter Nicholas Florko about the impact of Americans’ growing skepticism of science. Your co-hosts also chat about a clinical update from UniQure on its gene therapy for Huntington’s disease, a juicy lawsuit filed by the gene-editing company Beam Therapeutics against a Chinese competitor, and a shift in the way pharma companies like Novo and Eli Lilly are talking about their GLP-1 products.
- Sep 24, 202629 min
The FDA's Overton era, and dispatches from Shanghai
"The Readout LOUD" is going international this week. STAT's Jason Mast joins the podcast from Shanghai, where he's digging into what the rise of Chinese drug development means for the biotech industry. The hosts also speak to colleague Margaret Manto about Heidi Overton, the president's pick to be commissioner of the Food and Drug Administration. Will the new nominee bring some needed stability or controversy to the troubled agency? For more on Overton and her views on China, go here; to read about the ITM and Telix merger, go here; you can find the latest news on osteoporosis here.
- Sep 17, 202628 min
Definium's new psychedelics data, and a reprieve for international scientists
International researchers got a reprieve in the courts this week. But many are still considering leaving the states for opportunities elsewhere. What does that mean for the future of American medical research? We discuss that, plus the latest news in the life sciences, on this week's episode of "The Readout LOUD." STAT reporter Jonathan Wosen and Fanta Aw, the executive director of NAFSA: Association of International Educators, join the podcast to discuss a recent court decision around foreign visas for students. We also discuss the Definium's psychedelics data and what it means for that field as a whole. Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
Get The Readout Loud summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Stock Movers
Short conversations analyzing today's biggest gainers and losers in global stock markets across major sectors.
Science Magazine Podcast
Weekly episodes covering original scientific research, global science news, and expert commentary.
The Long Run with Luke Timmerman
In-depth conversations with biotech leaders navigating the challenges and opportunities of advancing science for human health.
Unbiased Science
Dr. Jess Steier and guests analyze viral health claims using scientific evidence and explain key findings for everyday conversations.
After the Fact
Explores data and trends shaping public health, environment, and economic issues through expert analysis and nonpartisan discussion.
The Best One Yet
A daily 20-minute podcast breaking down the three key business stories with sharp, accessible takes.
FDA Watch
A regulatory expert hosts discussions on FDA policies and developments across pharmaceuticals, devices, food, and cosmetics.
Solutions with Henry Blodget
Henry Blodget interviews experts in business, tech, and politics about practical solutions for building a better future.
The Pulse
Explores surprising stories in health and science, from operating rooms and labs to breakthrough innovations.
Science Quickly
A bite-sized science podcast exploring discoveries with journalists and experts.
Economist Podcasts
Daily global news analysis from correspondents on major international stories.
Biostatistics Podcast
A podcast exploring various topics in biostatistics.
About The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from The Readout Loud in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's The Readout Loud daily summary?
It's a free AI-powered email that summarizes new episodes of The Readout Loud as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the The Readout Loud podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official The Readout Loud product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by STAT.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does The Readout Loud release new episodes?
The Readout Loud publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does The Readout Loud cover?
The Readout Loud covers topics including Business. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting The Readout Loud summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.